Level Chart

Basic Info

Boston Scientific Corp (BSX) - Cardiovascular Organic Revenue Growth is at 25.60%, compared to 27.40% last quarter and 16.30% last year. This is higher than the long term average of 11.74%.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 25.60%
Latest Period Mar 2025
Last Updated Apr 30 2025, 09:20 EDT
Next Release Oct 31 2025, 08:30 EDT (E)
Long Term Average 11.74%
Average Growth Rate 265.1%
Value from Last Quarter 27.40%
Change from Last Quarter -6.57%
Value from 1 Year Ago 16.30%
Change from 1 Year Ago 57.06%
Frequency Quarterly
Unit Percent
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
March 31, 2025 25.60%
December 31, 2024 27.40%
September 30, 2024 24.60%
June 30, 2024 19.00%
March 31, 2024 16.30%
December 31, 2023 13.30%
September 30, 2023 10.60%
June 30, 2023 13.40%
March 31, 2023 14.40%
December 31, 2022 9.40%
September 30, 2022 12.60%
Date Value
June 30, 2022 7.80%
March 31, 2022 10.80%
December 31, 2021 27.00%
September 30, 2021 18.50%
June 30, 2021 43.90%
March 31, 2021 5.40%
December 31, 2020 -13.50%
September 30, 2020 -10.40%
June 30, 2020 -25.30%
March 31, 2020 -2.50%
December 31, 2019 10.00%

Basic Info

Boston Scientific Corp (BSX) - Cardiovascular Organic Revenue Growth is at 25.60%, compared to 27.40% last quarter and 16.30% last year. This is higher than the long term average of 11.74%.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 25.60%
Latest Period Mar 2025
Last Updated Apr 30 2025, 09:20 EDT
Next Release Oct 31 2025, 08:30 EDT (E)
Long Term Average 11.74%
Average Growth Rate 265.1%
Value from Last Quarter 27.40%
Change from Last Quarter -6.57%
Value from 1 Year Ago 16.30%
Change from 1 Year Ago 57.06%
Frequency Quarterly
Unit Percent
Adjustment N/A

Related Securities

Symbol Name Change %
BSX Boston Scientific Corp. -0.20%